Ning Zhou

2.8k total citations
81 papers, 1.9k citations indexed

About

Ning Zhou is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Ning Zhou has authored 81 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 28 papers in Molecular Biology and 20 papers in Epidemiology. Recurrent topics in Ning Zhou's work include COVID-19 Clinical Research Studies (10 papers), Cardiovascular Function and Risk Factors (9 papers) and Cardiac Fibrosis and Remodeling (7 papers). Ning Zhou is often cited by papers focused on COVID-19 Clinical Research Studies (10 papers), Cardiovascular Function and Risk Factors (9 papers) and Cardiac Fibrosis and Remodeling (7 papers). Ning Zhou collaborates with scholars based in China, United States and Japan. Ning Zhou's co-authors include Dao Wen Wang, Hongyang Shu, Weijian Hang, Yizhong Peng, Chenze Li, Hongyu Qiu, Ben Ma, Jiali Nie, Yunzeng Zou and Shaunrick Stoll and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Ning Zhou

74 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ning Zhou China 27 689 666 366 311 221 81 1.9k
Marta Brambilla Italy 24 424 0.6× 362 0.5× 186 0.5× 178 0.6× 222 1.0× 78 1.8k
Xingxiang Wang China 22 576 0.8× 426 0.6× 324 0.9× 101 0.3× 197 0.9× 63 1.7k
Qiu Zhang China 19 911 1.3× 200 0.3× 252 0.7× 279 0.9× 215 1.0× 79 2.2k
Jaana Rysä Finland 30 946 1.4× 857 1.3× 110 0.3× 172 0.6× 768 3.5× 113 2.8k
Michèle Bernier France 24 402 0.6× 342 0.5× 87 0.2× 191 0.6× 272 1.2× 55 1.8k
Sandra Rayego‐Mateos Spain 31 1.3k 1.9× 207 0.3× 126 0.3× 262 0.8× 325 1.5× 72 3.1k
Yan Han China 25 706 1.0× 380 0.6× 49 0.1× 269 0.9× 164 0.7× 107 1.9k
Liang Guo China 23 543 0.8× 81 0.1× 345 0.9× 290 0.9× 198 0.9× 116 1.8k
Zengxiang Dong China 22 691 1.0× 289 0.4× 63 0.2× 157 0.5× 105 0.5× 67 1.5k
Thorsten M. Leucker United States 21 451 0.7× 674 1.0× 67 0.2× 168 0.5× 520 2.4× 77 1.6k

Countries citing papers authored by Ning Zhou

Since Specialization
Citations

This map shows the geographic impact of Ning Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Zhou more than expected).

Fields of papers citing papers by Ning Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Zhou. The network helps show where Ning Zhou may publish in the future.

Co-authorship network of co-authors of Ning Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Zhou. A scholar is included among the top collaborators of Ning Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Zhou. Ning Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Deng, Ye, et al.. (2025). Efficacy of a novel artificial liver versatile plasma purification system in patients with acute-on-chronic liver failure. World Journal of Gastroenterology. 31(14). 103892–103892.
3.
4.
Qin, Liling, et al.. (2024). Rare atypical type a thymoma: a case report and literature review. Diagnostic Pathology. 19(1). 145–145.
5.
Zhou, Chao, et al.. (2024). The efficacy of 3D gait analysis to evaluate surgical (and rehabilitation) outcome after degenerative lumbar surgery. BMC Surgery. 24(1). 197–197. 2 indexed citations
6.
7.
Shu, Hongyang, Jia Cheng, Na Li, et al.. (2023). Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance. Cardiovascular Diabetology. 22(1). 192–192. 37 indexed citations
8.
Shu, Hongyang, Yizhong Peng, Weijian Hang, et al.. (2022). Emerging Roles of Ceramide in Cardiovascular Diseases. Aging and Disease. 13(1). 232–232. 42 indexed citations
9.
Zhu, Wei, Huaqiu Zhang, Yong Li, et al.. (2021). Optimizing Management to Reduce the Mortality of COVID-19: Experience From a Designated Hospital for Severely and Critically Ill Patients in China. Frontiers in Medicine. 8. 582764–582764. 6 indexed citations
10.
Wu, Lujin, et al.. (2021). Focus on Autoimmune Myocarditis in Graves' Disease: A Case-Based Review. Frontiers in Cardiovascular Medicine. 8. 678645–678645. 9 indexed citations
11.
Shen, Lan, Lin Qiu, Jingbo Liu, et al.. (2021). Clinical Implications of Nicorandil Combined with Trimetazidine in Patients with Coronary Heart Disease: A Real-World Observational Study. Advances in Therapy. 39(1). 655–673. 6 indexed citations
12.
Veronese, Giacomo, Enrico Ammirati, Chen Chen, et al.. (2020). Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis. International Journal of Cardiology. 324. 131–138. 18 indexed citations
13.
Zhou, Ning, Xin Chen, Jing Xi, et al.. (2020). Genomic characterization reveals novel mechanisms underlying the valosin-containing protein-mediated cardiac protection against heart failure. Redox Biology. 36. 101662–101662. 13 indexed citations
14.
Li, Sheng, Shengyong Xu, Chenze Li, et al.. (2019). A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: a multiple center study. Science China Life Sciences. 62(3). 369–380. 39 indexed citations
15.
Zhou, Ning, et al.. (2017). [Analysis of survival and influencing factors of HIV/AIDS patients in Tianjin, 2004-2014].. PubMed. 38(3). 369–373. 4 indexed citations
16.
Zhou, Ning, Jia‐Jye Lee, Shaunrick Stoll, et al.. (2016). Inhibition of SRF/myocardin reduces aortic stiffness by targeting vascular smooth muscle cell stiffening in hypertension. Cardiovascular Research. 113(2). 171–182. 50 indexed citations
17.
Jiang, Guoliang, Hui Gong, Yuhong Niu, et al.. (2015). Identification of Amino Acid Residues in Angiotensin II Type 1 Receptor Sensing Mechanical Stretch and Function in Cardiomyocyte Hypertrophy. Cellular Physiology and Biochemistry. 37(1). 105–116. 19 indexed citations
18.
Li, Lei, Ning Zhou, Hui Gong, et al.. (2010). Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice. Hypertension Research. 33(12). 1289–1297. 42 indexed citations
19.
Zhang, Shuning, Aijun Sun, Hong Ma, et al.. (2010). Infarcted myocardium‐like stiffness contributes to endothelial progenitor lineage commitment of bone marrow mononuclear cells. Journal of Cellular and Molecular Medicine. 15(10). 2245–2261. 25 indexed citations
20.
Zhou, Ning, Lei Li, Jian Wu, et al.. (2010). Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway. Biochemical and Biophysical Research Communications. 397(2). 263–269. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Brambilla Breakdown of academic impact, for papers by Xingxiang Wang Breakdown of academic impact, for papers by Qiu Zhang Breakdown of academic impact, for papers by Jaana Rysä Breakdown of academic impact, for papers by Michèle Bernier Breakdown of academic impact, for papers by Sandra Rayego‐Mateos Breakdown of academic impact, for papers by Yan Han Breakdown of academic impact, for papers by Liang Guo Breakdown of academic impact, for papers by Zengxiang Dong Breakdown of academic impact, for papers by Thorsten M. Leucker
Rankless by CCL
2026